Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Net Cash Flow (2023 - 2025)

Metagenomi (MGX) has disclosed Net Cash Flow for 3 consecutive years, with $8.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 291.98% to $8.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.3 million, a 112.61% increase, with the full-year FY2025 number at $14.3 million, up 112.61% from a year prior.
  • Net Cash Flow was $8.9 million for Q4 2025 at Metagenomi, up from $5.9 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $50.2 million in Q3 2023 to a low of -$88.8 million in Q1 2023.
  • A 3-year average of -$12.0 million and a median of -$268000.0 in 2025 define the central range for Net Cash Flow.
  • Peak YoY movement for Net Cash Flow: plummeted 171.77% in 2024, then surged 291.98% in 2025.
  • Metagenomi's Net Cash Flow stood at $38.7 million in 2023, then tumbled by 94.14% to $2.3 million in 2024, then soared by 291.98% to $8.9 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Net Cash Flow are $8.9 million (Q4 2025), $5.9 million (Q3 2025), and -$2.3 million (Q2 2025).